Back to 
DRIEHAUS CAPITAL MANAGEMENT LLC
DRIEHAUS CAPITAL MANAGEMENT LLC
AR2
Showing 0 of 3 quarters
Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in ARRAY BIOPHARMA INC
As of its Q2 2019 13F, Driehaus Capital Management held 432,003 shares of AR2 (Array Biopharma), worth $20M. Driehaus Capital Management's 13F filings listed AR2 from Q1 2019 to Q2 2019, 2 quarterly filings. AR2 was 0.6% of Driehaus Capital Management's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.